Psilocybin vs Ketamine-Assisted Psychotherapy and Cardiometabolic Outcomes
Carver College of Medicine
This clinical trial aims to compare the effects of psilocybin-assisted psychotherapy (PAP) and ketamine-assisted psychotherapy (KAP) on cardiometabolic health. The study will assess changes in biomarkers like blood pressure, cholesterol, and insulin resistance in participants with treatment-resistant depression. By comparing the two interventions, researchers hope to gain insights into their potential impact on physical health and identify the most effective treatment for improving both mental and physical well-being.